Login / Signup

Can we increase the drug survival time of biologic therapies in hidradenitis suppurativa?

Hans Christian RingJohn W FrewJacob P ThyssenAlexander EgebergSimon Francis Thomsen
Published in: Clinical and experimental dermatology (2022)
Keyphrases
  • hidradenitis suppurativa
  • rheumatoid arthritis
  • free survival
  • adverse drug
  • emergency department